• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫腺苷酸琥珀酸合成酶的独特动力学机制。

Unique kinetic mechanism of Plasmodium falciparum adenylosuccinate synthetase.

作者信息

Raman Jayalakshmi, Mehrotra Sonali, Anand Ranjith P, Balaram Hemalatha

机构信息

Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore 560064, India.

出版信息

Mol Biochem Parasitol. 2004 Nov;138(1):1-8. doi: 10.1016/j.molbiopara.2004.06.013.

DOI:10.1016/j.molbiopara.2004.06.013
PMID:15500910
Abstract

Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP. All characterized AdSS thus far exhibit a random kinetic mechanism. We present here kinetic evidence that unlike all other AdSS, Plasmodium falciparum AdSS (PfAdSS) has ordered substrate binding. Inhibition studies show that binding of GTP requires IMP binding while aspartate binds to the enzyme-IMP-GTP complex. A structural basis for this difference in mechanism is presented. Kinetically, PfAdSS is closer to the mouse acidic isozyme rather than to the mouse basic isozyme. The mouse acidic isozyme is thought to play a role in the purine nucleotide biosynthetic pathway. Regulation of PfAdSS in vivo can therefore, be expected to be similar to the mouse acidic isozyme, in agreement with the role of PfAdSS as the only pathway for the synthesis of adenine nucleotides in the parasite. However, PfAdSS differs from both the mammalian homologs in that fructose-1,6-bisphosphate, a potent inhibitor of the mammalian enzyme, is an activator of PfAdSS. The differences highlighted here are promising in terms of species-specific drug design, targeting this essential enzyme in the parasite.

摘要

腺苷酸琥珀酸合成酶(AdSS)催化由肌苷酸(IMP)和天冬氨酸依赖镁离子形成腺苷酸琥珀酸,该反应由三磷酸鸟苷(GTP)水解为二磷酸鸟苷(GDP)驱动。迄今为止,所有已鉴定的AdSS均表现出随机动力学机制。我们在此提供动力学证据,表明与所有其他AdSS不同,恶性疟原虫AdSS(PfAdSS)具有有序的底物结合。抑制研究表明,GTP的结合需要IMP的结合,而天冬氨酸则与酶-IMP-GTP复合物结合。本文还提出了这种机制差异的结构基础。从动力学角度来看,PfAdSS更接近小鼠酸性同工酶而非小鼠碱性同工酶。小鼠酸性同工酶被认为在嘌呤核苷酸生物合成途径中起作用。因此,可以预期PfAdSS在体内的调节与小鼠酸性同工酶相似,这与PfAdSS作为寄生虫中腺嘌呤核苷酸合成的唯一途径的作用一致。然而,PfAdSS与两种哺乳动物同源物的不同之处在于,果糖-1,6-二磷酸是哺乳动物酶的强效抑制剂,却是PfAdSS的激活剂。这里强调的差异在针对该寄生虫中这种必需酶的物种特异性药物设计方面很有前景。

相似文献

1
Unique kinetic mechanism of Plasmodium falciparum adenylosuccinate synthetase.恶性疟原虫腺苷酸琥珀酸合成酶的独特动力学机制。
Mol Biochem Parasitol. 2004 Nov;138(1):1-8. doi: 10.1016/j.molbiopara.2004.06.013.
2
Studies on active site mutants of P. falciparum adenylosuccinate synthetase: insights into enzyme catalysis and activation.恶性疟原虫腺苷酸琥珀酸合成酶活性位点突变体的研究:对酶催化和激活的见解
Biochim Biophys Acta. 2010 Oct;1804(10):1996-2002. doi: 10.1016/j.bbapap.2010.07.015. Epub 2010 Aug 1.
3
Kinetic characterization of adenylosuccinate synthetase from the thermophilic archaea Methanocaldococcus jannaschii.嗜热古菌詹氏甲烷球菌腺苷酸琥珀酸合成酶的动力学特性
Biochemistry. 2007 Nov 6;46(44):12821-32. doi: 10.1021/bi701009y. Epub 2007 Oct 11.
4
Crystal structure of fully ligated adenylosuccinate synthetase from Plasmodium falciparum.恶性疟原虫完全结合的腺苷酸琥珀酸合成酶的晶体结构
J Mol Biol. 2004 Jan 30;335(5):1251-64. doi: 10.1016/j.jmb.2003.11.036.
5
Purification and characterization of recombinant Plasmodium falciparum adenylosuccinate synthetase expressed in Escherichia coli.在大肠杆菌中表达的重组恶性疟原虫腺苷酸琥珀酸合成酶的纯化与鉴定
Protein Expr Purif. 2002 Jun;25(1):65-72. doi: 10.1006/prep.2001.1610.
6
A mathematical model for the adenylosuccinate synthetase reaction involved in purine biosynthesis.一种参与嘌呤生物合成的腺苷酸琥珀酸合成酶反应的数学模型。
Theor Biol Med Model. 2007 Feb 27;4:11. doi: 10.1186/1742-4682-4-11.
7
Involvement of arginine 143 in nucleotide substrate binding at the active site of adenylosuccinate synthetase from Escherichia coli.大肠杆菌腺苷酸琥珀酸合成酶活性位点处精氨酸143参与核苷酸底物结合。
Biochemistry. 1996 Jul 16;35(28):9024-33. doi: 10.1021/bi960426j.
8
Implication of arginine-131 and arginine-303 in the substrate site of adenylosuccinate synthetase of Escherichia coli by affinity labeling with 6-(4-bromo-2,3-dioxobutyl)thioadenosine 5'-monophosphate.通过用6-(4-溴-2,3-二氧代丁基)硫代腺苷5'-单磷酸进行亲和标记研究大肠杆菌腺苷琥珀酸合成酶底物位点中精氨酸-131和精氨酸-303的作用
Biochemistry. 1999 May 4;38(18):5754-63. doi: 10.1021/bi982779j.
9
Mechanism of action of Escherichia coli phosphoribosylaminoimidazolesuccinocarboxamide synthetase.大肠杆菌磷酸核糖氨基咪唑琥珀酰胺羧酰胺合成酶的作用机制。
Biochemistry. 2005 Jan 18;44(2):766-74. doi: 10.1021/bi048191w.
10
Structure-function studies of adenylosuccinate synthetase from Escherichia coli.来自大肠杆菌的腺苷酸琥珀酸合成酶的结构-功能研究
Arch Biochem Biophys. 1999 Oct 1;370(1):1-8. doi: 10.1006/abbi.1999.1383.

引用本文的文献

1
Metabolic changes accompanying the loss of fumarate hydratase and malate-quinone oxidoreductase in the asexual blood stage of Plasmodium falciparum.伴随疟原虫无性血期富马酸水合酶和苹果酸-醌氧化还原酶缺失的代谢变化。
J Biol Chem. 2022 May;298(5):101897. doi: 10.1016/j.jbc.2022.101897. Epub 2022 Apr 6.
2
Antimalarial Properties of Isoquinoline Derivative from subsp. Hygroscopicus: An In Silico Approach.从 Hygroscopicus 的亚种中提取的异喹啉衍生物的抗疟特性:一种计算机模拟方法。
Biomed Res Int. 2020 Jan 9;2020:6135696. doi: 10.1155/2020/6135696. eCollection 2020.
3
In the quest for new targets for pathogen eradication: the adenylosuccinate synthetase from the bacterium Helicobacter pylori.
在寻找新的病原体根除靶点的过程中:来自细菌幽门螺杆菌的腺嘌呤基琥珀酸合成酶。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1405-1414. doi: 10.1080/14756366.2018.1506773.
4
Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase.通过破坏苹果酸:醌氧化还原酶抑制实验性脑疟疾
Malar J. 2017 Jun 12;16(1):247. doi: 10.1186/s12936-017-1898-5.
5
Structural insight into binding mode of inhibitor with SAHH of and human: interaction of curcumin with anti-malarial drug targets.抑制剂与疟原虫和人类的SAHH结合模式的结构洞察:姜黄素与抗疟药物靶点的相互作用
J Chem Biol. 2016 Aug 15;9(4):107-120. doi: 10.1007/s12154-016-0155-7. eCollection 2016 Oct.
6
Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria.嘌呤补救的过渡态抑制剂和疟疾中的其他潜在酶靶标。
Future Med Chem. 2013 Jul;5(11):1341-60. doi: 10.4155/fmc.13.51.
7
Purine and pyrimidine pathways as targets in Plasmodium falciparum.疟原虫中的嘌呤和嘧啶代谢途径作为靶点。
Curr Top Med Chem. 2011;11(16):2103-15. doi: 10.2174/156802611796575948.
8
Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum.疟原虫红内期嘌呤补救途径的副产物延胡索酸盐的代谢命运。
J Biol Chem. 2011 Mar 18;286(11):9236-45. doi: 10.1074/jbc.M110.173328. Epub 2011 Jan 5.
9
Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds.在新型抗疟化合物中鉴定假定疟疾药物靶点的抑制剂。
Mol Biochem Parasitol. 2011 Jan;175(1):21-9. doi: 10.1016/j.molbiopara.2010.08.005. Epub 2010 Sep 15.